GKOS ▲ +8.5% - Glaukos Corporation
$GKOS Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus
07-OCT-2026 04:05 PM ET
Share this post
More filings for $GKOS
GKOS ▲ +8.5% - Glaukos CorporationOct 7, 2026GKOS ▼ -0.1% - Glaukos CorporationOct 7, 2026GKOS ▲ +0.0% - Glaukos CorporationSep 23, 2026
View full $GKOS filing history →💬 Comments
Loading comments…
Leave a comment
